Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Screening for Aplaviroc Phase 3 Studies
NCT00123890Phase 3Terminated
- Sponsor
- GSK
- Start
- Jun 2005
- Primary completion
- Oct 2005
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 3, open-label, single-arm trial of aplaviroc in human immunodeficiency virus infection (HIV), sponsored by GSK. Primary endpoint: Determination of subject eligibility. Started Jun 2005; status: terminated.
02
Drugs
aplaviroc
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00123890.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00123890.